Management of Hepatic Metastases from Colorectal Cancer

 

 Buy Article Permissions and Reprints

ABSTRACT

The majority of hepatic metastases in the United States occur in patients with a primary colorectal malignancy. Advances in technology combined with increasing surgeon experience have broadened the treatment options available for hepatic metastases from colorectal cancer. Surgical resection is the most effective therapy for metastatic colorectal cancer isolated to the liver. The aim of this article is to discuss the role of locally aggressive treatment options including resection, ablation, and regional chemotherapy in the management of patients with metastases from colorectal cancer.

REFERENCES

• 1 Jemal A, Thomas A, Murray T et al.. Cancer statistics.  CA Cancer J Clin. 2002;  52 23-47
  CrossrefPubMedGoogle Scholar
• 2 Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.  Cancer. 1969;  23 198-202
  CrossrefPubMedGoogle Scholar
• 3 Cady B, Monson D, Swinton N. Survival of patients after colonic resection for carcinoma with simultaneous liver metastases.  Surg Gynecol Obstet. 1970;  131 697-700
  PubMedGoogle Scholar
• 4 Scoggins C, Meszoely I, Blanke C et al.. Nonoperative management of primary colorectal cancer in patients with stage IV disease.  Ann Surg Oncol. 1999;  6 651-657
  CrossrefPubMedGoogle Scholar
• 5 Ohlsson B, Tranberg K, Lundstedt C et al.. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods.  Eur J Surg. 1993;  159 275-281
  PubMedGoogle Scholar
• 6 Finlay I, McArdle C S. Occult hepatic metastases in colorectal carcinoma.  Br J Surg. 1986;  73 732-735
  PubMedGoogle Scholar
• 7 Lefor A, Hughes K, Shiloni E et al.. Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases.  Dis Colon Rectum. 1988;  31 100-103
  PubMedGoogle Scholar
• 8 Ries L, Miller B, Hankey B et al.. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Report no. NIH-94-2789. Bethesda, MD; National Cancer Institute 1994
  Google Scholar
• 9 Jessup J, McGinnis L, Steele G J et al.. The national cancer data base report on colon cancer.  Cancer. 1996;  78 918-926
  CrossrefPubMedGoogle Scholar
• 10 Moertel C, Fleming T, MacDonald J et al.. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.  Ann Intern Med. 1995;  122 321-326
  CrossrefPubMedGoogle Scholar
• 11 Shelton A, Wong W. Colorectal cancer. In: Cameron J Current Surgical Therapy St. Louis; Mosby 1998: 217-227
  Google Scholar
• 12 Martin R, Paty P, Fong Y et al.. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.  J Am Coll Surg. 2003;  197 233-242
  CrossrefPubMedGoogle Scholar
• 13 Blumgart L H, Allison D J. Resection and embolization in the management of secondary hepatic tumors.  World J Surg. 1982;  6 32-45
  CrossrefPubMedGoogle Scholar
• 14 Fong Y, Fortner J, Sun R L et al.. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.  Ann Surg. 1999;  230 309-318
  CrossrefPubMedGoogle Scholar
• 15 Fong Y, Blumgart L H. Hepatic colorectal metastases: current status of surgical therapy.  Oncology. 1998;  12 1489-1498
  PubMedGoogle Scholar
• 16 Fong Y, Cohen A M, Fortner J G et al.. Liver resection for colorectal metastases.  J Clin Oncol. 1997;  15 938-946
  CrossrefPubMedGoogle Scholar
• 17 Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.  Br J Surg. 1990;  77 1241-1246
  CrossrefPubMedGoogle Scholar
• 18 Wagner J, Adson M, van Heerden J et al.. The natural history of hepatic metastases from colorectal cancer.  Ann Surg. 1984;  199 502-508
  CrossrefPubMedGoogle Scholar
• 19 Rougier P, Milan C, Lazorthes F et al.. Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer.  Br J Surg. 1995;  82 1397-1400
  CrossrefPubMedGoogle Scholar
• 20 Lahr C, Soong S, Cloud G et al.. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.  J Clin Oncol. 1983;  1 720-725
  PubMedGoogle Scholar
• 21 Wood C, Gillis C, Blumgart L. A retrospective study of the natural history of patients with liver metastases from colorectal cancer.  Clin Oncol. 1976;  2 285-288
  PubMedGoogle Scholar
• 22 Pestana C, Reitemeier R, Moertel C et al.. The natural history of carcinoma of the colon and rectum.  Am J Surg. 1964;  108 826-829
  CrossrefPubMedGoogle Scholar
• 23 Welch J, Donaldson G. The clinical correlation of an autopsy study of recurrent colorectal cancer.  Ann Surg. 1979;  189 496-502
  PubMedGoogle Scholar
• 24 Gilbert H, Kagan A. Metastases: incidence, detection, and evaluation without histologic confirmation. In: Weiss L Fundamental Aspects of Metastasis Amsterdam; North-Holland Publishing 1976: 385-405
  Google Scholar
• 25 Scheele J, Stang R, Atendorf-Hofmann A, Paul M. Resection of colorectal liver metastases.  World J Surg. 1995;  19 59-71
  Google Scholar
• 26 Moran B, O'Rourke N, Plant G, Rees M. Computed tomographic portography in preoperative imaging of hepatic neoplasms.  Br J Surg. 1995;  82 669-671
  PubMedGoogle Scholar
• 27 McDermott V, Lawrance J, Paulson E et al.. CT during arterial portography: comparison of injection into the splenic versus superior mesenteric artery.  Radiology. 1996;  199 627-631
  PubMedGoogle Scholar
• 28 Fernandez F G, Drebin J A, Linehan D C et al.. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose(FDG-PET).  Ann Surg. 2004;  240 438-450
  CrossrefPubMedGoogle Scholar
• 29 Soyer P, Levesque M, Elias D. Detection of liver metastases from colorectal cancer: comparison of intraoperative ultrasound and CT during arterial portography.  Radiology. 1992;  183 541-544
  PubMedGoogle Scholar
• 30 Conlon R, Jacobs M, Dasgupta D et al.. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative MRI.  Eur J Ultrasound. 2003;  16 211-216
  CrossrefPubMedGoogle Scholar
• 31 Grobmyer S R, Fong Y, D’Angelica M et al.. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.  Arch Surg. 2004;  139 1326-1330
  CrossrefPubMedGoogle Scholar
• 32 Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group.  J Clin Oncol. 1992;  10 904-911
  CrossrefPubMedGoogle Scholar
• 33 Scheithauer W, Rosen H, Kornek G et al.. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.  BMJ. 1993;  306 752-755
  CrossrefPubMedGoogle Scholar
• 34 Saltz L, Shimada Y, Khayat D. CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer.  Eur J Cancer. 1996;  32A(suppl 3) S24-S31
  PubMedGoogle Scholar
• 35 Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.  Ann Oncol. 2003;  14 13-16
  PubMedGoogle Scholar
• 36 Leonard G D, Brenner B, Kemeny N. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.  J Clin Oncol. 2005;  23 2038-2048
  CrossrefPubMedGoogle Scholar
• 37 Hurwitz H, Fehrenbacher L, Novotny W et al.. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.  N Engl J Med. 2004;  350 2335-2342
  CrossrefPubMedGoogle Scholar
• 38 Hamady Z Z, Kotru A, Nishio H et al.. Current techniques and results of liver resection for colorectal liver metastases.  Br Med Bull. 2004;  70 87-104
  PubMedGoogle Scholar
• 39 Elias D, Oullet J F, De Baere T et al.. Pre-operative selective portal vein embolization before hepatectomy for liver metastases.  Surgery. 2002;  131 294-299
  CrossrefPubMedGoogle Scholar
• 40 Adam R, Laurent A, Azoulay D et al.. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors.  Ann Surg. 2000;  232 777-785
  CrossrefPubMedGoogle Scholar
• 41 Minagawa M, Makuuchi M, Torzilli G et al.. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.  Ann Surg. 2000;  231 487-499
  CrossrefPubMedGoogle Scholar
• 42 Ambiru S, Miyazaki M, Isono T et al.. Hepatic resection for colorectal metastases: analysis of prognostic factors.  Dis Colon Rectum. 1999;  42 632-639
  PubMedGoogle Scholar
• 43 Jamison R, Donohue J, Nagorney D et al.. Hepatic resection for metastatic colorectal cancer results in cure for some.  Arch Surg. 1997;  132 505-511
  PubMedGoogle Scholar
• 44 Gayowski T, Iwatsuki S, Madariaga J et al.. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.  Surgery. 1994;  116 703-711
  PubMedGoogle Scholar
• 45 Doci R, Bignami P, Montalto F, Gennari L. Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection.  Tumori. 1995;  81(3 suppl) 143-146
  PubMedGoogle Scholar
• 46 Jaeck D, Bachellier P, Guiguet M et al.. Survival benefit of repeat liver resection for recurrent colorectal metastases: 143 cases.  Wiad Lek. 1997;  50(suppl 1) 102-104
  PubMedGoogle Scholar
• 47 Fong Y, Blumgart L, Cohen A et al.. Repeat hepatic resections for metastatic colorectal cancer.  Ann Surg. 1994;  220 657-662
  CrossrefPubMedGoogle Scholar
• 48 Fernandez-Trigo V, Shamsa F, Sugarbaker P. Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry.  Surgery. 1995;  117 296-304
  CrossrefPubMedGoogle Scholar
• 49 Petrowsky H, Gonen M, Jarnigan W et al.. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis.  Ann Surg. 2002;  235 863-871
  CrossrefPubMedGoogle Scholar
• 50 Choti M A, Sitzmann J V, Tiburi M F et al.. Trends in long term survival following liver resection for hepatic colorectal metastases.  Ann Surg. 2002;  235 759-766
  CrossrefPubMedGoogle Scholar
• 51 Ng K K, Poon R T. Radiofrequency ablation for malignant liver tumor.  Surg Oncol. 2005;  14 41-52
  CrossrefPubMedGoogle Scholar
• 52 Abdalla E K, Vauthey J N, Ellis L M et al.. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.  Ann Surg. 2004;  239 818-827
  CrossrefPubMedGoogle Scholar
• 53 Wood T F, Rose D M, Chung M et al.. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limits, and complications.  Ann Surg Oncol. 2000;  7 593-600
  Google Scholar
• 54 Bowles B J, Machi J, Limm W ML et al.. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors.  Arch Surg. 2001;  136 864-869
  PubMedGoogle Scholar
• 55 Curley S A, Izzo F, Ellis L M et al.. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.  Ann Surg. 2000;  232 381-391
  CrossrefPubMedGoogle Scholar
• 56 Barber F D, Mavligit G, Kurzock R. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.  Cancer Treat Rev. 2004;  30 425-436
  CrossrefPubMedGoogle Scholar
• 57 Onaitis M, Morse M, Hurwitz H et al.. Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases.  Ann Surg. 2003;  237 782-788
  CrossrefPubMedGoogle Scholar
• 58 Martin R C, Edwards M J, McMasters K M. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.  Am J Surg. 2004;  188 714-721
  CrossrefPubMedGoogle Scholar

Ketan R ShethM.D. 

Division of Hepatobiliary Surgery, Duke University Medical Center

104 Bell Bldg., Durham, NC 27710

Email: ketan.sheth@duke.edu